United States Varicella Vaccine Market Report 2017

August 2017 | 104 pages | ID: UDEFDCAD420EN
QYResearch

Abstracts

In this report, the United States Varicella Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Varicella Vaccine in these regions, from 2012 to 2022 (forecast).

United States Varicella Vaccine market competition by top manufacturers/players, with Varicella Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Merck & Co.
• Sanofi Pasteur
• Green Cross
• Shanghai Institute
• BCHT
• Changsheng
• Keygen
• Biken

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Monovalent Vaccine
• Combination Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Varicella Vaccine for each application, including

• Children
• Teenagers
• Adults

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Varicella Vaccine Market Report 2017

1 VARICELLA VACCINE OVERVIEW

1.1 Product Overview and Scope of Varicella Vaccine
1.2 Classification of Varicella Vaccine by Product Category
  1.2.1 United States Varicella Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Varicella Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Monovalent Vaccine
  1.2.4 Combination Vaccine
1.3 United States Varicella Vaccine Market by Application/End Users
  1.3.1 United States Varicella Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Children
  1.3.3 Teenagers
  1.3.4 Adults
1.4 United States Varicella Vaccine Market by Region
  1.4.1 United States Varicella Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Varicella Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Varicella Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Varicella Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Varicella Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Varicella Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Varicella Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Varicella Vaccine (2012-2022)
  1.5.1 United States Varicella Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Varicella Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES VARICELLA VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Varicella Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Varicella Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Varicella Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Varicella Vaccine Market Competitive Situation and Trends
  2.4.1 United States Varicella Vaccine Market Concentration Rate
  2.4.2 United States Varicella Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Varicella Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES VARICELLA VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Varicella Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Varicella Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Varicella Vaccine Price by Region (2012-2017)

4 UNITED STATES VARICELLA VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Varicella Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Varicella Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Varicella Vaccine Price by Type (2012-2017)
4.4 United States Varicella Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES VARICELLA VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Varicella Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Varicella Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES VARICELLA VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Varicella Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Varicella Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck & Co.
  6.2.2 Varicella Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck & Co. Varicella Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi Pasteur
  6.3.2 Varicella Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Pasteur Varicella Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Green Cross
  6.4.2 Varicella Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Green Cross Varicella Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Shanghai Institute
  6.5.2 Varicella Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Shanghai Institute Varicella Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 BCHT
  6.6.2 Varicella Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 BCHT Varicella Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Changsheng
  6.7.2 Varicella Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Changsheng Varicella Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Keygen
  6.8.2 Varicella Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Keygen Varicella Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biken
  6.9.2 Varicella Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biken Varicella Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 VARICELLA VACCINE MANUFACTURING COST ANALYSIS

7.1 Varicella Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Varicella Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Varicella Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Varicella Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES VARICELLA VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Varicella Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Varicella Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Varicella Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Varicella Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Varicella Vaccine
Figure United States Varicella Vaccine Market Size (K Units) by Type (2012-2022)
Figure United States Varicella Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Monovalent Vaccine Product Picture
Figure Combination Vaccine Product Picture
Figure United States Varicella Vaccine Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Varicella Vaccine by Application in 2016
Figure Children Examples
Table Key Downstream Customer in Children
Figure Teenagers Examples
Table Key Downstream Customer in Teenagers
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure United States Varicella Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Varicella Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Varicella Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Varicella Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Varicella Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Varicella Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Varicella Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Varicella Vaccine Sales (K Units) and Growth Rate (2012-2022)
Figure United States Varicella Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Varicella Vaccine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Varicella Vaccine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Varicella Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Varicella Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Varicella Vaccine Sales Share by Players/Suppliers
Figure United States Varicella Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Varicella Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Varicella Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Varicella Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Varicella Vaccine Revenue Share by Players/Suppliers
Table United States Market Varicella Vaccine Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Varicella Vaccine Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Varicella Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Varicella Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Varicella Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Varicella Vaccine Product Category
Table United States Varicella Vaccine Sales (K Units) by Region (2012-2017)
Table United States Varicella Vaccine Sales Share by Region (2012-2017)
Figure United States Varicella Vaccine Sales Share by Region (2012-2017)
Figure United States Varicella Vaccine Sales Market Share by Region in 2016
Table United States Varicella Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Varicella Vaccine Revenue Share by Region (2012-2017)
Figure United States Varicella Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Varicella Vaccine Revenue Market Share by Region in 2016
Table United States Varicella Vaccine Price (USD/Unit) by Region (2012-2017)
Table United States Varicella Vaccine Sales (K Units) by Type (2012-2017)
Table United States Varicella Vaccine Sales Share by Type (2012-2017)
Figure United States Varicella Vaccine Sales Share by Type (2012-2017)
Figure United States Varicella Vaccine Sales Market Share by Type in 2016
Table United States Varicella Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Varicella Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Varicella Vaccine by Type (2012-2017)
Figure Revenue Market Share of Varicella Vaccine by Type in 2016
Table United States Varicella Vaccine Price (USD/Unit) by Types (2012-2017)
Figure United States Varicella Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Varicella Vaccine Sales (K Units) by Application (2012-2017)
Table United States Varicella Vaccine Sales Market Share by Application (2012-2017)
Figure United States Varicella Vaccine Sales Market Share by Application (2012-2017)
Figure United States Varicella Vaccine Sales Market Share by Application in 2016
Table United States Varicella Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Varicella Vaccine Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Varicella Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Varicella Vaccine Sales Growth Rate (2012-2017)
Figure GSK Varicella Vaccine Sales Market Share in United States (2012-2017)
Figure GSK Varicella Vaccine Revenue Market Share in United States (2012-2017)
Table Merck & Co. Basic Information List
Table Merck & Co. Varicella Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Varicella Vaccine Sales Growth Rate (2012-2017)
Figure Merck & Co. Varicella Vaccine Sales Market Share in United States (2012-2017)
Figure Merck & Co. Varicella Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Varicella Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Varicella Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur Varicella Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi Pasteur Varicella Vaccine Revenue Market Share in United States (2012-2017)
Table Green Cross Basic Information List
Table Green Cross Varicella Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Green Cross Varicella Vaccine Sales Growth Rate (2012-2017)
Figure Green Cross Varicella Vaccine Sales Market Share in United States (2012-2017)
Figure Green Cross Varicella Vaccine Revenue Market Share in United States (2012-2017)
Table Shanghai Institute Basic Information List
Table Shanghai Institute Varicella Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shanghai Institute Varicella Vaccine Sales Growth Rate (2012-2017)
Figure Shanghai Institute Varicella Vaccine Sales Market Share in United States (2012-2017)
Figure Shanghai Institute Varicella Vaccine Revenue Market Share in United States (2012-2017)
Table BCHT Basic Information List
Table BCHT Varicella Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BCHT Varicella Vaccine Sales Growth Rate (2012-2017)
Figure BCHT Varicella Vaccine Sales Market Share in United States (2012-2017)
Figure BCHT Varicella Vaccine Revenue Market Share in United States (2012-2017)
Table Changsheng Basic Information List
Table Changsheng Varicella Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Changsheng Varicella Vaccine Sales Growth Rate (2012-2017)
Figure Changsheng Varicella Vaccine Sales Market Share in United States (2012-2017)
Figure Changsheng Varicella Vaccine Revenue Market Share in United States (2012-2017)
Table Keygen Basic Information List
Table Keygen Varicella Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Keygen Varicella Vaccine Sales Growth Rate (2012-2017)
Figure Keygen Varicella Vaccine Sales Market Share in United States (2012-2017)
Figure Keygen Varicella Vaccine Revenue Market Share in United States (2012-2017)
Table Biken Basic Information List
Table Biken Varicella Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biken Varicella Vaccine Sales Growth Rate (2012-2017)
Figure Biken Varicella Vaccine Sales Market Share in United States (2012-2017)
Figure Biken Varicella Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Varicella Vaccine
Figure Manufacturing Process Analysis of Varicella Vaccine
Figure Varicella Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Varicella Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Varicella Vaccine
Table Distributors/Traders List
Figure United States Varicella Vaccine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Varicella Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Varicella Vaccine Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Varicella Vaccine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Varicella Vaccine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Varicella Vaccine Sales Volume (K Units) Forecast by Type in 2022
Table United States Varicella Vaccine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Varicella Vaccine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Varicella Vaccine Sales Volume (K Units) Forecast by Application in 2022
Table United States Varicella Vaccine Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Varicella Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Varicella Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Varicella Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources